**Core Concept**
The question is testing the understanding of the pathophysiology of glaucoma and the mechanism of action of certain drugs used in its management. The trabecular meshwork is a critical structure in the eye that regulates the outflow of aqueous humor, and drugs that act on this site can affect intraocular pressure (IOP).

**Why the Correct Answer is Right**
The correct answer is a drug that acts on the trabecular meshwork to increase the outflow of aqueous humor, thereby reducing IOP and treating glaucoma. This drug works by increasing the permeability of the trabecular meshwork to aqueous humor, allowing it to drain more efficiently. The exact mechanism of action involves the inhibition of beta-adrenergic receptors in the trabecular meshwork, which leads to increased outflow.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not specifically target the trabecular meshwork. Instead, it acts on a different site in the eye to reduce IOP.
* **Option B:** This option is incorrect because it is a drug that reduces the production of aqueous humor, rather than increasing its outflow.
* **Option C:** This option is incorrect because it is not a drug that is typically used to treat glaucoma, and it does not have a mechanism of action that involves the trabecular meshwork.

**Clinical Pearl / High-Yield Fact**
The trabecular meshwork is a critical site for the treatment of glaucoma, and drugs that act on this site can be effective in reducing IOP and preventing vision loss.

**Correct Answer: B. Latanoprost**